In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Acutus Medical gets $100mm via Series D, $70mm credit facility

Executive Summary

Acutus Medical Inc. (diagnostic imaging devices for arrhythmias) raised $100mm in a Series D financing from first-time backers including 8VC, Opaleye Management, Pura Vida Investments, and returning shareholders OrbiMed, Deerfield Management, Advent Venture Partners, Xeraya Capital, and GE Ventures. In addition, OrbiMed Credit and Royalties Fund and Deerfield Management provided the firm with a $70mm credit facility. The company will use the proceeds for commercialization of FDA-approved and CE-Marked AcQMap cardiac imaging and mapping system and FDA-cleared vascular access products AcQCross QX, AcQGuide Flex, and AcQGuide Mini.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Financing
    • Nonconvertible Debt
    • Venture Financing

Related Companies